精品啪啪一级免费视频 武汉原生原代生物医药科技有限公司

贺中国科学院工程研究所和清华大学生命科学学院应用PriCe

时间:2021-09-06
分享:

  
贺中国科学院工程研究所和清华大学生命科学学院应用PriCells产品/技术服务发表文章
 
Activated Scavenger Receptor A Promotes Glial Internalization of Ab
 
PLOS ONE Published: April 09,2014 DOI:10.1371/journal.pone.0094197
 
He Zhang1,2, Ya-jing Su3, Wei-wei Zhou1, Shao-wei Wang1, Peng-xin Xu1, Xiao-lin Yu1*, Rui-tian Liu1*
 
National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China,
Tsinghua University School of Medicine, Haidian District, Beijing, China, 
3 School of Life Science, Ningxia University, Yinchuan, China
 
Abstract
Beta-amyloid (Aβ) aggregates have a pivotal role in pathological processing of Alzheimer’s disease (AD). The clearance of Aβ monomer or aggregates is a causal strategy for AD treatment. Microglia and astrocytes are the main macrophages that exert critical neuroprotective roles in the brain. They may effectively clear the toxic accumulation of Aβ at the initial stage of AD, however, their functions are attenuated because of glial overactivation. In this study, we first showed that heptapeptide XD4 activates the class A scavenger receptor (SR-A) on the glia by increasing the binding of Aβ to SR-A, thereby promoting glial phagocytosis of Aβ oligomer in microglia and astrocytes and triggering intracellular mitogen-activated protein kinase (MAPK) signaling cascades. Moreover, XD4 enhances the internalization of Aβ monomers to microglia and astrocytes through macropinocytosis or SR-A-mediated phagocytosis. Furthermore, XD4 significantly inhibits Aβ oligomer-induced cytotoxicity to glial cells and decreases the production of proinflammatory cytokines, such as TNF-α and IL-1β, in vitro and in vivo. Our findings may provide a novel strategy for AD treatment by activating SR-A.
 
MIC-CELL-0077 / MED-0014,PriCells



会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

X
该信息已收藏!
标签:
保存成功

(空格分隔,最多3个,单个标签最多10个字符)

常用:

提示

X
您的留言已提交成功!我们将在第一时间回复您~
拨打电话 产品分类
在线留言